Published March 19, 2018 | Version 1
Preprint Open

Update on fragment screening of ACVR1 co_crystallised with LDN_193189

Creators

  • 1. University of Oxford

Description

Update on fragment screening of ACVR1 with LDN-193189

Notes

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].

Files

Files (15.4 kB)